T. Nakano

发表

Biochemical basis of antigen-specific suppressor T cell factors: controversies and possible answers.

Y. Ishii, K. Sugie, K. Ishizaka, 2000, Advances in immunology.

Transcription of biliary glycoprotein I gene in malignant and non‐malignant human liver tissues

R. Paxton, K. Imai, Y. Hinoda, 1990, International journal of cancer.

Presence of the 55 kDa glycosylation inhibiting factor in human serum.

Y. Ishii, K. Ishizaka, T. Nakano, 2000, International immunology.

Association between expression of intercellular adhesion molecule‐1 and integration of human T‐cell‐leukemia virus type 1 in adult T‐cell leukemia cells

K. Imai, Y. Hinoda, M. Tsujisaki, 1997, Journal of clinical laboratory analysis.

Preparation of soluble recombinant T cell receptor alpha chain by using a calmodulin fusion expression system.

Y. Ishii, N. Honma, H. Watarai, 1995, Journal of immunological methods.

High-affinity binding of bioactive glycosylation-inhibiting factor to antigen-primed T cells and natural killer cells.

T. Mikayama, K. Sugie, K. Ishizaka, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Conversion of inactive glycosylation inhibiting factor to bioactive derivatives by modification of a SH group.

T. Mikayama, H. Watarai, K. Ishizaka, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Cellular mechanisms for the formation of a soluble form derivative of T-cell receptor alpha chain by suppressor T cells.

Y. Ishii, K. Ishizaka, T. Nakano, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Biochemical characterization of antigen-specific glycosylation-inhibiting factor from antigen-specific suppressor T cells. II. The 55-kDa glycosylation-inhibiting factor peptide is a derivative of TCR alpha-chain and a subunit of antigen-specific glycosylation-inhibiting factor.

Y. Ishii, K. Ishizaka, T. Nakano, 1996, Journal of immunology.

Biochemical characterization of antigen-specific glycosylation-inhibiting factor from antigen-specific suppressor T cells. I. Identification of a 55-kilodalton glycosylation-inhibiting factor peptide with TCR alpha-chain determinant.

Y. Ishii, K. Ishizaka, T. Nakano, 1996, Journal of immunology.

Association of the "major histocompatibility complex subregion" I-J determinant with bioactive glycosylation-inhibiting factor.

M. Taniguchi, T. Mikayama, H. Watarai, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Requirement of posttranslational modifications for the generation of biologic activity of glycosylation-inhibiting factor.

C. Elly, K. Ishizaka, T. Nakano, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Controversial issues and possible answers on the antigen-specific regulation of the IgE antibody response.

Y. Ishii, T. Mikayama, A. Mori, 1996, Advances in experimental medicine and biology.

Immunosuppressive activities of recombinant glycosylation-inhibiting factor mutants.

R. Kuroki, A. Iwamatsu, N. Honma, 1999, Journal of immunology.

Mutants FactorRecombinant Glycosylation-Inhibiting Immunosuppressive Activities of Kimishige

R. Kuroki, A. Iwamatsu, N. Honma, 1998 .

Molecular cloning and functional expression of a cDNA encoding glycosylation-inhibiting factor.

Y. Ishii, Yun-Cai Liu, A. Iwamatsu, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Association of the

Yun-Cai Liu, M. Taniguchi, T. Mikayama, 1995 .